Regavirumab

Regavirumab
Monoclonal antibody
Type Whole antibody
Source Human
Target cytomegalovirus glycoprotein B
Clinical data
ATC code none
Identifiers
CAS Number 153101-26-9 N
ChemSpider none
 NYesY (what is this?)  (verify)

Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.[1]

References

  1. Arizono, H; Sugano, T; Kaida, S; Shibusawa, K; Karasawa, Y; Esumi, Y; Kondo, S; Kiyoki, M (1994). "Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys". Arzneimittel-Forschung. 44 (7): 909–13. PMID 7945531.


This article is issued from Wikipedia - version of the 10/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.